151 related articles for article (PubMed ID: 16225764)
1. Multivesicular liposome formulations for the sustained delivery of interferon alpha-2b.
Qiu J; Wei XH; Geng F; Liu R; Zhang JW; Xu YH
Acta Pharmacol Sin; 2005 Nov; 26(11):1395-401. PubMed ID: 16225764
[TBL] [Abstract][Full Text] [Related]
2. Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon alpha.
Vyas SP; Rawat M; Rawat A; Mahor S; Gupta PN
Drug Dev Ind Pharm; 2006 Jul; 32(6):699-707. PubMed ID: 16885125
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of an extended-release human interferon alpha-2b formulation.
Bonetti A; Kim S
Cancer Chemother Pharmacol; 1993; 33(3):258-61. PubMed ID: 8269608
[TBL] [Abstract][Full Text] [Related]
4. A novel method to prepare highly encapsulated interferon-alpha-2b containing liposomes for intramuscular sustained release.
Yang L; Yang W; Bi D; Zeng Q
Eur J Pharm Biopharm; 2006 Aug; 64(1):9-15. PubMed ID: 16797953
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation, pharmacokinetics and tissue distribution of interferon α-2b liposomes after intramuscular injection to rats.
Li H; Yang L; Cheng G; Wei HY; Zeng Q
Arch Pharm Res; 2011 Jun; 34(6):941-8. PubMed ID: 21725815
[TBL] [Abstract][Full Text] [Related]
6. Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: preparation, characterization, and pharmacokinetics.
Shen Y; Ji Y; Xu S; Chen DQ; Tu J
Drug Deliv; 2011 Jul; 18(5):361-6. PubMed ID: 21428705
[TBL] [Abstract][Full Text] [Related]
7. Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugs.
Yuan L; Wang J; Shen WC
J Control Release; 2008 Jul; 129(1):11-7. PubMed ID: 18448186
[TBL] [Abstract][Full Text] [Related]
8. [Obtaining and characteristics of domestic preparation interferon alpha-2b with prolonged effect].
Pokholenko IaA; Porubleva LV; Dubeĭ IIa; Rebriev AV; Sutugina LP; Gromovoĭ TIu; Pokrovskiĭ VA; Obolenskaia MIu; Chernykh SI
Ukr Biokhim Zh (1999); 2008; 80(6):92-100. PubMed ID: 19351063
[TBL] [Abstract][Full Text] [Related]
9. Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology.
Zhao Y; Liu J; Sun X; Zhang ZR; Gong T
Drug Dev Ind Pharm; 2010 Jul; 36(7):823-31. PubMed ID: 20515403
[TBL] [Abstract][Full Text] [Related]
10. Multivesicular liposome formulation for the sustained delivery of breviscapine.
Zhong H; Deng Y; Wang X; Yang B
Int J Pharm; 2005 Sep; 301(1-2):15-24. PubMed ID: 16023316
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.
Angst MS; Drover DR
Clin Pharmacokinet; 2006; 45(12):1153-76. PubMed ID: 17112293
[TBL] [Abstract][Full Text] [Related]
12. Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery.
Jain SK; Gupta Y; Jain A; Bhola M
Drug Deliv; 2007 Aug; 14(6):327-35. PubMed ID: 17701522
[TBL] [Abstract][Full Text] [Related]
13. Protamine modified metal ion-protein chelate microparticles for sustained release of interferon.
Jiang Y; Shi K; Xia D; Piao H; Quan P; Song T; Cui F
Int J Pharm; 2011 Apr; 407(1-2):31-7. PubMed ID: 21220001
[TBL] [Abstract][Full Text] [Related]
14. Development of interferon alpha-2b microspheres with constant release.
Li Z; Li L; Liu Y; Zhang H; Li X; Luo F; Mei X
Int J Pharm; 2011 May; 410(1-2):48-53. PubMed ID: 21419205
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of recombinant human interferon-alpha-2b poly(lactic-co-glycolic acid) microspheres in rats.
Yang F; Shu YJ; Yang YQ; Song FL; Pan YF; Long XY; Chen G; Zhang YM
J Microencapsul; 2011; 28(6):483-9. PubMed ID: 21718088
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of sustained release multivesicular liposome for thymopentin and preliminary study on its pharmacokinetics in rats].
Jiao YH; Sun KX; Mu HJ; Wang T; Yao DG; Yuan ZZ
Yao Xue Xue Bao; 2008 Jul; 43(7):756-60. PubMed ID: 18819482
[TBL] [Abstract][Full Text] [Related]
17. Liposome associated interferon-alpha-2b functions as an anti-fibrogenic factor in dermal wounds in the guinea pig.
Ghahary A; Tredget EE; Shen Q; Kilani RT; Scott PG; Takeuchi M
Mol Cell Biochem; 2000 May; 208(1-2):129-37. PubMed ID: 10939636
[TBL] [Abstract][Full Text] [Related]
18. Preparation and investigation of core-shell nanoparticles containing human interferon-α.
Kristó K; Szekeres M; Makai Z; Márki Á; Kelemen A; Bali L; Pallai Z; Dékány I; Csóka I
Int J Pharm; 2020 Jan; 573():118825. PubMed ID: 31715360
[TBL] [Abstract][Full Text] [Related]
19. [Interferon alpha-2b modified with polyethylene glycol].
Wu Y; Zhai Y; Lei J; Ma G; Su Z
Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1658-63. PubMed ID: 19160853
[TBL] [Abstract][Full Text] [Related]
20. Liposome-associated interferon-alpha-2b functions as an anti-fibrogenic factor for human dermal fibroblasts.
Ghahary A; Shen Q; Rogers JA; Wang R; Fathi-Afshar A; Scott PG; Tredget EE
J Invest Dermatol; 1997 Jul; 109(1):55-60. PubMed ID: 9204955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
